Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors have?
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors has 458 citations in the OpenAlex counts ScholarIQ stores.
When was Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors published?
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors has 2011 year in the ScholarIQ index.
What is the open-access status of Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors has hybrid oa status in the ScholarIQ index.
What is the DOI of Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?
The DOI for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is on the source record.
What is the PMID of Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?
The PMID for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is on the source record.
What is the OpenAlex record for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?
The OpenAlex for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is on the source record.